Post-mortem from Canaccord HCV conference: I recommend the afternoon panel discussion, which included the head of marketing at VRUS and the CMO at VRTX. On the other hand, the lunchtime panel from HCV clinicians was a waste of time, IMO.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”